NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Reflux esophagitis
Date of first enrollment	19/10/2009
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : TAK-438 INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Oral administration

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	1. Endoscopic diagnosis of grade A to D reflux esophagitis by LA classification at the start of the follow-up period (visit 1), etc.
Exclude criteria	1. Complications that may affect the esophagus, history of esophageal radiotherapy or cryotherapy, or presence of corrosive or physiochemical trauma 2. History of surgery for reflux esophagitis, dilation of esophageal stricture, or surgery of the stomach or duodenum 3. Acute upper gastrointestinal bleeding or active gastric or duodenal ulcer within 30 days prior to the start of the follow-up period, etc.